Ignite Creation Date:
2024-10-25 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06569355
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-20
Brief Title:
A Study to Evaluate the Efficacy and Safety of VCT220 in Obesity Chinese Population
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multi-center Randomized Double-blind Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VCT220 Tablets in Overweightobese Subjects
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of the study is to assess how VCT220 tablets affect the bodyweight when used once daily in obese or overweight adult participants
Qualified participants will be randomly assigned to one of four groups using a computerized system Participants will get VCT220 or placebo tablets for 16 weeks and will need to take tablets each morning
Participants will have 7 clinic visits and a final follow-up visit approximately 14 days after the last study intervention administration
Qualified participants will be randomly assigned to one of four groups using a computerized system Participants will get VCT220 or placebo tablets for 16 weeks and will need to take tablets each morning
Participants will have 7 clinic visits and a final follow-up visit approximately 14 days after the last study intervention administration
Detailed Description:
Not provided
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None